Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03701308
Title Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Recruitment Suspended
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)

acute myeloid leukemia


Cytarabine + Daunorubicin

Cytarabine + Uproleselan

Cytarabine + Daunorubicin + Uproleselan


Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST